While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

After the U.S. withdrew from the World Health Organization, it wasn't clear they would participate in this WHO-led meeting to determine the recipe for the next flu vaccine.

The president’s pick for surgeon general is a vaccine skeptic. During her Senate confirmation hearing Wednesday, Casey Means ...

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...

Scientists at Stanford University say they are developing a single nasal spray vaccine that could protect against coughs, ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

A potential massive breakthrough!

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Jessica Mendoza: Liz, we're both here in DC, and I don't know about you, but I ...

A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable ...

The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk. The FDA’s defense ...

After the FDA's surprise refusal to take up a review of Moderna's next-gen flu vaccine, the public disagreement between U.S. regulators and the mRNA specialist took a new turn Wednesday, with the U.S.

The U.S. is experiencing its worst flu season in decades. More than 180,000 people have been hospitalized with the flu this winter, and 7,400 have died, according to the U.S. Centers for Disease ...